Literature DB >> 8204568

Platelet serotonergic markers in psychiatric disorders: use, abuse and limitations.

P D Hrdina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8204568      PMCID： PMC1188571     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  13 in total

1.  Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes.

Authors:  A G Saltzman; B Morse; M M Whitman; Y Ivanshchenko; M Jaye; S Felder
Journal:  Biochem Biophys Res Commun       Date:  1991-12-31       Impact factor: 3.575

2.  [3H]paroxetine binding in human platelets in relation to age and sex.

Authors:  A Andersson; J Marcusson
Journal:  Neurobiol Aging       Date:  1990 Nov-Dec       Impact factor: 4.673

3.  Does platelet serotonin receptor supersensitivity accompany endogenous depression?

Authors:  O S Brusov; B S Beliaev; A B Katasonov; G P Zlobina; M I Factor; R R Lideman
Journal:  Biol Psychiatry       Date:  1989-02-15       Impact factor: 13.382

4.  Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.

Authors:  K Maguire; V Tuckwell; A Pereira; B Dean; B Singh
Journal:  Biol Psychiatry       Date:  1993-09-15       Impact factor: 13.382

5.  Protein kinase C translocation in human blood platelets.

Authors:  H Y Wang; E Friedman
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

6.  Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.

Authors:  P D Hrdina
Journal:  Biol Psychiatry       Date:  1989-03-01       Impact factor: 13.382

7.  Seasonal variations in binding of 3H-paroxetine to blood platelets in healthy volunteers: indications for a gender difference.

Authors:  J L Klompenhouwer; D Fekkes; A M van Hulst; P Moleman; L Pepplinkhuizen; P G Mulder
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

8.  Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.

Authors:  K M Lawrence; J Falkowski; R R Jacobson; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.

Authors:  R C Arora; H Y Meltzer
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

10.  Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients.

Authors:  M S Briley; S Z Langer; R Raisman; D Sechter; E Zarifian
Journal:  Science       Date:  1980-07-11       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.